Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Mahmoodreza Khoonsari's publication output changed over time?
ScholarIQpublication output · 2014–2025
Output grew0% over the shown period — from 1 works in 2014 to 1 in 2025.
1
1
1
1
3
1
1
1
1
201420152017202020212022202320242025
What are the most-cited papers on Mahmoodreza Khoonsari?
ScholarIQmost cited works
Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Haleh Chehrehgosha, Masoudreza Sohrabi, Faramarz Ismail‐Beigi, Mojtaba Malek, Mohammad Reza Babaei, Farhad Zamani, Hossein Ajdarkosh, Mahmoodreza Khoonsari, Afshin Eshghi Fallah, Mohammad E. Khamseh
Diabetes Therapy. 2021175 CitationsOPEN ACCESS
Prevalence of colorectal adenoma in an average-risk population aged 40–50 versus 50–60 years
Gholamreza Hemmasi, Masoudreza Sohrabi, Farhad Zamani, Hossein Ajdarkosh, Nasser Rakhshani, Mahmoodreza Khoonsari, Mitra Ameli, Khadijeh Hatami
European Journal of Cancer Prevention. 201443 Citations
Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease
Mahmoodreza Khoonsari, Mohammad Reza Mohammad Hoseini Azar, Ramak Ghavam, Khadijeh Hatami, Mosa Asobar, Ali Gholami, Abdolhalim Rajabi, Fahimeh Safarnezhad Tameshkel, Bahare Amirkalali, Masoudreza Sohrabi
S2765036875. 201742 CitationsOPEN ACCESS
SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran
Alireza Tabibzadeh, Farhad Zamani, Azadeh Laali, Maryam Esghaei, Fahimeh Safarnezhad Tameshkel, Hossein Keyvani, Mahin Jamshidi Makiani, Mahshid Panahi, Nima Motamed, Dhayaneethie Perumal, Mahmoodreza Khoonsari, Hossein Ajdarkosh, Masuodreza Sohrabi, Behrooz Ghanbari, Shokoufeh Savaj, Alireza Mosavi-Jarrahi, Mohammad Hadi Karbalaie Niya
S142765166. 202030 CitationsOPEN ACCESS
The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study
Nima Motamed, Mehdi Nikkhah, Mohammad Hadi Karbalaie Niya, Mahmoodreza Khoonsari, Dhayaneethie Perumal, G. Hossein Ashrafi, Amir H. Faraji, Mansooreh Maadi, Hossein Ajdarkosh, Fahimeh Safarnezhad Tameshkel, Maziar Moradi‐Lakeh, Seyyed Mohammad Miri, Shahram Arsang‐Jang, Farhad Zamani
Clinics and Research in Hepatology and Gastroenterology. 202125 Citations
Related on ScholarIQ
Iran University of Medical Sciences
Institution
Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Paper
Prevalence of colorectal adenoma in an average-risk population aged 40–50 versus 50–60 years
Paper
Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease
Paper
SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran
Paper
The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study
Paper